Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine + propofol minimum effective dose for MRI sedation in children with spastic quadriplegic cerebral palsy
ChiCTR2600135956Phase 4Completed
- Sponsor
- Nanhai District Maternal and Child Health Hospital of Foshan City
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine and propofol in spastic tetraplegia, sponsored by Nanhai District Maternal and Child Health Hospital of Foshan City. Primary endpoint: Time to onset of sedation. Started Jan 2025; status: completed.
02
Drugs
dexmedetomidinepropofol
03
Conditions
spastic tetraplegia
Beyond the preview
Go deeper on ChiCTR2600135956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135956.